Federal contract award
W81K0025PA125
THE GOVERNMENTS REQUIREMENT IS TO ESTABLISH A COST-PER-KIT AGREEMENT TO INCLUDE REAGENTS, CONSUMABLES, CONTROLS, AND ANY NECESSARY PRODUCTS TO CONDUCT ALL REQUIRED TESTING FOR THE CHEMILUMINESCENCE IMMUNOASSAY (CLIA) REAGENTS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $290.9K |
| Current contract value | $1.2M |
| Potential contract value / ceiling | $4.0M |
| Start date | Oct 1, 2025 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2030 |
| Latest award activity | May 7, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 7, 2026 | P00003 | $-632.0K | THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY26 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE CONTRACT IN FY26 (01 OCTOBER 2025 - 30 SEPTEMBER 2026). |
| Dec 17, 2025 | P00002 | $922.9K | IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-25-P-A125 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026. |
| Dec 16, 2025 | P00001 | $0 | THIS IS AN ADMINISTRATIVE MODIFICATION TO DELIVERY ORDER W81K00-25-P-A125 TO REMOVE THE PAYMENT OFFICE INFORMATION DUE TO THE HS2 FUNDS VALIDATION ERROR. |
| Jul 25, 2025 | 0 | $0 | THE GOVERNMENTS REQUIREMENT IS TO ESTABLISH A COST-PER-KIT AGREEMENT TO INCLUDE REAGENTS, CONSUMABLES, CONTROLS, AND ANY NECESSARY PRODUCTS TO CONDUCT ALL REQUIRED TESTING FOR THE CHEMILUMINESCENCE IMMUNOASSAY (CLIA) REAGENTS. |
Estimated positioning window
Sep 30, 2029 – Mar 30, 2030
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2030-09-30 (1429 days from calculation)
- +5 points
- 80 historical awards in this buyer and category group
- +15 points
- 4 recorded award transactions
- +10 points
- Latest award action: 2026-05-07
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.